INVO Bioscience, Inc. (INVO) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Sarasota, FL, United States. The current CEO is Steven M. Shum.
INVO has IPO date of 2020-11-02, 25 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $3.25M.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
